A detailed history of Daiwa Securities Group Inc. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 215 shares of TBPH stock, worth $2,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares
215
Previous 15 1333.33%
Holding current value
$2,040
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.66 - $10.25 $1,532 - $2,050
200 Added 1333.33%
215 $2,000
Q2 2024

Aug 07, 2024

SELL
$8.29 - $9.92 $1,657 - $1,984
-200 Reduced 93.02%
15 $0
Q4 2021

Feb 03, 2022

BUY
$7.42 - $11.05 $704 - $1,049
95 Added 79.17%
215 $2,000
Q4 2020

Feb 04, 2021

SELL
$14.89 - $20.16 $3,394 - $4,596
-228 Reduced 65.52%
120 $2,000
Q1 2020

May 14, 2020

BUY
$17.84 - $31.21 $499 - $873
28 Added 8.75%
348 $8,000
Q4 2019

Jan 31, 2020

SELL
$16.12 - $25.89 $531 - $854
-33 Reduced 9.35%
320 $7,000
Q1 2019

Apr 26, 2019

BUY
$22.57 - $28.15 $7,967 - $9,936
353 New
353 $8,000
Q4 2018

Feb 05, 2019

SELL
$22.52 - $35.07 $6,733 - $10,485
-299 Closed
0 $0
Q1 2018

May 02, 2018

BUY
$23.37 - $29.71 $6,987 - $8,883
299 New
299 $7,000

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $634M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.